Punga AR - Search Results

1

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

Phillips WD, Christadoss P, Losen M, Punga AR, Shigemoto K, Verschuuren J, Vincent A. Phillips WD, et al. Among authors: punga ar. Exp Neurol. 2015 Aug;270:29-40. doi: 10.1016/j.expneurol.2014.12.013. Epub 2014 Dec 24. Exp Neurol. 2015. PMID: 25542979

2

Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.

Punga AR, Flink R, Askmark H, Stålberg EV. Punga AR, et al. Muscle Nerve. 2006 Jul;34(1):111-5. doi: 10.1002/mus.20515. Muscle Nerve. 2006. PMID: 16453324

3

Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice.

Punga AR, Lin S, Oliveri F, Meinen S, Rüegg MA. Punga AR, et al. Exp Neurol. 2011 Aug;230(2):207-17. doi: 10.1016/j.expneurol.2011.04.018. Epub 2011 Apr 30. Exp Neurol. 2011. PMID: 21565192

4

Neurophysiological characteristics of MuSK antibody positive myasthenia gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors.

Chroni E, Punga AR. Chroni E, et al. Among authors: punga ar. J Neurol Sci. 2012 May 15;316(1-2):150-7. doi: 10.1016/j.jns.2011.12.016. Epub 2012 Jan 16. J Neurol Sci. 2012. PMID: 22251934

5

Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study.

Askmark H, Haggård L, Nygren I, Punga AR. Askmark H, et al. Among authors: punga ar. Eur J Neurol. 2012 Dec;19(12):1554-60. doi: 10.1111/j.1468-1331.2012.03773.x. Epub 2012 Jun 4. Eur J Neurol. 2012. PMID: 22672742 Clinical Trial.

6

Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK+) experimental autoimmune Myasthenia gravis (EAMG).

Chauhan M, Punga T, Punga AR. Chauhan M, et al. Among authors: punga ar, punga t. Neurosci Res. 2013 Sep-Oct;77(1-2):102-9. doi: 10.1016/j.neures.2013.07.008. Epub 2013 Aug 7. Neurosci Res. 2013. PMID: 23933211

7

Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients.

Punga AR, Andersson M, Alimohammadi M, Punga T. Punga AR, et al. Among authors: punga t. J Neurol Sci. 2015 Sep 15;356(1-2):90-6. doi: 10.1016/j.jns.2015.06.019. Epub 2015 Jun 14. J Neurol Sci. 2015. PMID: 26095457 Free article.

8

Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.

Punga T, Bartoccioni E, Lewandowska M, Damato V, Evoli A, Punga AR. Punga T, et al. Among authors: punga ar. J Neuroimmunol. 2016 Mar 15;292:21-6. doi: 10.1016/j.jneuroim.2016.01.003. Epub 2016 Jan 7. J Neuroimmunol. 2016. PMID: 26943954 Free article.

9

Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients.

Molin CJ, Westerberg E, Punga AR. Molin CJ, et al. Among authors: punga ar. Sci Rep. 2017 Jan 3;7:39716. doi: 10.1038/srep39716. Sci Rep. 2017. PMID: 28045063 Free PMC article.

10

Circulating microRNAs as potential biomarkers in myasthenia gravis patients.

Punga AR, Punga T. Punga AR, et al. Among authors: punga t. Ann N Y Acad Sci. 2018 Jan;1412(1):33-40. doi: 10.1111/nyas.13510. Epub 2017 Nov 10. Ann N Y Acad Sci. 2018. PMID: 29125182 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters